Press Coverage

FDA Panel Gives Exparel Thumbs Down as Regional Nerve Block

Article on the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee vote against recommending bupivacaine liposomal injectable suspension (Exparel) as a nerve block to treat regional postsurgical pain quotes ISMP’s Medical Director. For the full text of the article, please visit Medscape online.

Topics
People

More News